Skip to content

    Hindustan Foods

    HNDFDS
    Fast Moving Consumer Goods·27 May 2026
    Management Summary

    Hindustan Foods delivered a strong Q4 and full-year FY26, achieving record profitability and revenue growth despite macroeconomic and geopolitical challenges. The company successfully completed a significant capex cycle of over ₹700 crores, expanding capacities and integrating acquisitions. While the footwear division faced margin pressure from raw material inflation, management remains confident in achieving its FY27 PAT guidance of ₹200-220 crores, driven by new project pipeline and operational efficiencies.

    Highlights

    5

    • FY26 total income grew 17% YoY to ₹4,264 crores, demonstrating strong top-line performance.

    • FY26 PAT increased 29% YoY to ₹149 crores, reflecting healthy operating leverage and improved utilization.

    • Q4 FY26 marked the strongest quarterly performance with PAT up 32% YoY to ₹41.5 crores.

    • Successfully commissioned new factories and integrated acquisitions, laying a strong foundation for future growth.

    • Maintained net debt to equity at 0.84x, well within the comfort level of 1x, despite significant capex.

    Concerns

    3

    • Footwear division faced headwinds in Q4 FY26 due to rising petrochemical prices (50-60% increase in polymers) and increased freight rates, impacting profitability.

    • Temporary LPG shortage affected two factories, though costs were passed on.

    • Cash flow impacted by higher working capital deployment due to GST rate changes (inverted duty structure) and proactive inventory buildup.

    Key financials

    Metrics

    7

    Periods

    2

    Q4 FY26

    4
    • Total Income
      ₹1,120 Cr
      YoY+17%
    • EBITDA
      ₹104 Cr
      YoY+28.0%
    • PBT
      ₹58.2 Cr
      YoY+40%
    • PAT
      ₹41.5 Cr
      YoY+32%

    FY26

    3
    • Total Income
      ₹4,264 Cr
      YoY+17%
    • EBITDA
      ₹377 Cr
      YoY+20%
    • PAT
      ₹149 Cr
      YoY+29.0%

    Segment breakdown

    Footwear Division
    ₹500 Cr FY26 Turnover
    List

    Capital allocation

    6
    high confidence
    CategoryHeadline
    Capex

    ₹700 crores

    Debt

    0.8x EBITDA

    M&A

    Aurangabad Personal Care facility

    acquisition · integrated

    M&A

    Cone manufacturing facility

    acquisition · integrated

    M&A

    Baddi acquisition

    acquisition · integrated

    Guidance & targets

    8
    CategoryTargetPriority
    Profitability
    PAT
    ₹200-220 crores
    		High
    Profitability
    ROCE (Individual Project Level)
    18%
    		High
    Profitability
    EBITDA Margin
    10%
    		High
    Turnover
    Footwear Division Turnover
    ₹700-800 crores
    		Medium
    Capex
    New Projects Signed
    ₹150 crores
    		High
    Growth
    EBITDA Growth (per division)
    20%
    		High
    Growth
    Overall Company Growth
    20%
    		High
    Debt
    Net Debt to Equity
    Below 1x
    		High

    Further FY27 Capex Announcements

    Next few quarters / by end of FY27
    Current₹150 crores signed
    TargetAdditional projects beyond ₹150 crores

    Why it matters

    Management indicated the ₹150 crores is just the initial signed amount and expects more, which is crucial for future growth.

    We do have a strong pipeline of projects that we are discussing. We generally, as a policy, do not give out the number unless the contracts have been signed. And we are reasonably confident💬 that number of INR150 crores, I forget the adjective that you used but will not be as small as you think by the end of this year. (Sameer Kothari, page 19)

    How to verify

    capital_allocation.capex.fy_planned

    Risks & concerns

    5
    RiskSeverity

    Macroeconomic and geopolitical headwinds

    Affected raw material prices (petrochemicals, polymers up 50-60%) and freight rates, particularly impacting the footwear division. — Management acknowledged

    medium

    LPG shortage

    Temporarily affected two factories, though increased costs were passed on to customers. — Management acknowledged

    low

    GST rate changes (inverted duty structure)

    Impacted cash flow due to higher working capital deployment and necessitates transition to net revenue model for certain businesses, affecting reported revenue. — Management acknowledged

    medium

    Higher working capital deployment

    Due to GST changes and proactive inventory buildup to safeguard supply chain continuity amid geopolitical environment. — Management acknowledged

    medium

    Uncertainty around global supply chains

    Makes it a challenging time to acquire new customers, especially for exports, but company is taking a contrarian approach. — Management acknowledged

    medium

    Q&A highlights

    7

    “So we should be about INR700 crores to INR800 crores of turnover as far as shoes is concerned in this FY27. Profitability target is something that I would much rather not talk about, especially for this division right now because there's just too much variability in terms of the raw material prices and our discussions with the customers are still ongoing.”

    Analyst sought quantification of sales and profitability for a segment facing significant headwinds, but management only provided sales guidance, citing raw material price volatility for profitability.

    asked by Abhishek Mathur

    2 min read6 chapters

    Detailed Narrative

    01

    Strong Financial Performance in FY26

    Hindustan Foods reported a robust financial performance for FY26, with total income increasing by 17% year-on-year to ₹4,264 crores. EBITDA grew by 20% year-on-year to ₹377 crores, and Profit After Tax (PAT) reached a record high of ₹149 crores, marking a 29% year-on-year growth. The fourth quarter of FY26 was particularly strong, with PAT increasing by 32% year-on-year to ₹41.5 crores, making it the best quarterly performance in the company's history.

    02

    Strategic Capex and Capacity Expansion

    FY26 was a milestone year for HFL, undertaking an ambitious capex of over ₹700 crores. This investment led to the commercialization of significant assets, with the gross block increasing to ₹1,800 crores as of March 2026. For FY27, the company has already signed new projects worth approximately ₹150 crores, including ₹50 crores each in beverages, HPC, and ice cream capacities. The Panipat plant was commissioned in April 2026 in less than 10 months, and the company is expanding its beverage platform and entering the Greek yogurt segment.

    03

    Operational Highlights and New Capacities

    The company's divisions performed well, with seasonal businesses like beverages and ice creams delivering record volume growth. The Aurangabad Personal Care facility has been successfully integrated, enhancing capabilities for D2C and premium products. The Silvassa liquid detergent project and Lucknow detergent bar facility are expected to be operational in FY27. The acquisition of the cone manufacturing facility and commissioning of the stick manufacturing facility are key steps in backward integration for the ice cream division.

    04

    Challenges in Footwear Division and Working Capital

    The footwear division faced significant headwinds in Q4 FY26 due to rising petrochemical prices, with polymers increasing by 50-60%, and higher freight rates. While the company aims for ₹700-800 crores turnover in footwear for FY27, profitability remains uncertain due to ongoing raw material price volatility. Cash flow was impacted by higher working capital deployment, primarily due to GST rate changes under the inverted duty structure and proactive inventory buildup to ensure supply chain continuity.

    05

    Guidance and Future Outlook

    HFL remains confident in achieving its FY27 PAT guidance of ₹200-220 crores. The company targets a 20% EBITDA growth across its five divisions and an overall company growth of 20%. It aims to maintain an 18% Return on Capital Employed (ROCE) at the individual project level and keep net debt to equity below 1x. Management expects the transition to a net revenue model for certain businesses, due to GST inversion, to start in Q2 and conclude by Q3 FY27, which will impact reported revenues but not absolute profitability.

    06

    Healthcare Business Expansion

    The healthcare business strengthened its manufacturing quality and product development capabilities, adding new customers and completing several domestic and international regulatory audits in FY26. The company is establishing a dedicated Ayurvedic wellness manufacturing facility at Baddi and expanding its presence in wellness and Ayurveda. Exports are a key focus, with the Head of Exports expected to provide updates in the coming quarters.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.